A pilot nonrandomized study including 93 patients with RA showed that RANKL levels and the RANKL/OPG ratio significantly decreased in both serum and interleukin 1 beta-induced RA fibroblast-like synoviocytes after treatment with IGU [49]. The gene discussed is IL1B; the disease is rheumatoid arthritis.